All In MedTech

FDA Clearance Tracker · P180013-S007

VICI VENOUS STENT System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 29, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P180013-S007
Device name
VICI VENOUS STENT System
Applicant location
Marborough, MA
Received
Apr 6, 2021
Decided
Jun 29, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P180013

Device type

Device class
Class III

Every decision under product code QAN

FDA's approval statement

As written in FDA's record.

Approval for labeling update which incorporates the final 3-year results from the VIRTUS Continued Follow-Up Study of patients enrolled in the premarket study

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.